Life Science

Cisa Group produces washing and sterilization equipment for life science industries.


Laboratory washing machines and instrument washers, glassware washers
cage washing
biosafety level 1 sterilization, biosafety level 2 sterilization
biosafety level 3 sterilization, biosafety level 4 sterilization
Waste management
icona Waste WSD
icona Waste WSM

Washing systems for Life Science applications

The LS washing range offers specially designed solutions for washing and sanitising glassware, all types of laboratory equipment and animal care equipment in fish farms and animal facilities, such as pipettes, feeding bottles, cages and fish tanks.


Space-saving compact technologies are available for facilities with limited productivity. Equipment of a size and capacity appropriate to the needs of large research centres, usually accustomed to handling a high volume of equipment, completes the range.

Cisa Life Science washing systems are easy to use and offer fast and reliable cycles, tested for their specific applications.

The drying system is extremely efficient, helping to ensure maximum cleanliness, hygiene and safety while minimising the risk of cross-contamination.

Sterilisation systems for the Life Science sector

The LS range of sterilisers is specifically designed for laboratory applications ranging from the treatment of glassware and other autoclavable equipment with solid cycles to processes with more demanding requirements such as liquid cycles and biohazardous materials.

Ease of use and versatility are the hallmarks of this highly configurable range, which includes compact, small machines and large models with chamber volumes in excess of five thousand litres. Performance and production reliability are ensured by short and efficient cycles, validated in accordance with standard regulations. It is also possible to customise the containment system according to customer requirements, risk level and respective BSL (BSL1, BSL2, BSL3 and BSL4).

These technologies ensure the maximum safety of the production process, preventing any leakage of hazardous pathogens to protect personnel, the surrounding community and the environment.


Infectuous Waste Treatment Systems by Cisa Waste sector

Cisa Waste, an end-to-end technology, is the new frontier in infectous  waste treatment.

Completely sustainable, the WSD® solution, and the WSM mobile version, allow the healthcare facility to achieve ambitious sustainability objectives: reduction of waste volumes to be treated, reduction of treatment costs and related risks, including CO2 emissions.


The innovative process reduces the amount of waste to be disposed of and promotes maximum recovery: reuse in energy production and recycling of polymeric materials, giving them a new life.

Bridging Science and Life

Cisa Life Science supports scientists,

researchers and engineers involved in the study and treatment of diseases.

The scientific research process

Life Science Applications

Cisa Life Science equipment are designed for scientific laboratories, research centers, and pharmaceutical companies, active in the development and manufacturing of life-enhancing products.

Technologies, products and solutions for scientific applications and animal laboratories





• BSL1 and BLS 2
• BSL3 and BLS 4

Technologies and solutions for research centers where clinical trials are carried out



• BSL1 and BLS 2
• BSL3 and BLS 4


Technologies for the autoclave sterilization of pharmaceutical industry products






What the 4 Biosafety levels (BSL) are

Infectious agents are classified according to biological safety. Bacteria, viruses, parasites and fungi are microorganisms that could cause infection, allergy or intoxication in humans. Infectious agents are divided into four groups according to the risk of infection for individuals and communities, which varies from zero, low, up to moderate and high risk.

Each risk group must necessarily correspond to an appropriate Biosafety Level in the laboratory: Biosafety Level BSL 1 BSL 2 BSL 3 BSL 4.

Covid-19 and the Biosafety Level

For example, at the time of its spread, during the first wave and before the release of the vaccine therapy, the Covid-19 virus was in the BSL 4 biosafety level group. Memories of healthcare workers being equipped with all the necessary devices to tend to patients in intensive care in the spring of 2020 are still fresh. As a result of the vaccine, the Covid-19 Corona virus was downgraded to Risk Group 3 with a BSL 3 biosafety level and the choice of procedures and personal protective equipment has been redefined numerous times in relation to this safety level for researchers, healthcare workers and communities.

The definitions: biosafety, biosecurity and biocontainment.

Biosafety (Laboratory biosafety)

is the term to describe standards, technologies and containment practices that are implemented to prevent unintentional exposures or accidental releases of pathogens and toxins.

The assignment of a given Biosafety level for laboratory activities with a specific microorganism arises from a complex and comprehensive risk assessment analysis that goes beyond automatic assignment according to the level of risk to which the pathogen belongs: it evaluates the possible risks from handling a hazard and the existing control measures in order to decide whether the risk is acceptable or not. In a risk assessment for a laboratory facility, the following is taken into account:

  • the microorganism used
  • the specific processes to be carried out
  • the facilities and equipment available
  • the operating practices and procedures necessary to work safely

The information identified by the Risk Assessment will provide a guide to select the Biosafety Level (BSL) appropriate to the situation, select appropriate microbiological practices, identify Personal Protective Equipment (PPE) and draw up the necessary security procedures to prevent Laboratory Acquired Infections (LAIs).

Biosecurity (Laboratory biosecurity)

refers to institutional and personal security measures designed to prevent loss, theft, misuse, accidental or intentional release of pathogens or toxins.

Effective biosafety practices (such as the choice of specific PPE) are the fundamental basis for biosecurity activities in laboratories and research centres.

The terms containment practices and unintentional exposures perfectly describe what is meant by the other term useful in understanding the importance of biosafety levels and the reasons for their classification and application.

The term Biocontainment refers to methods, procedures, equipment and apparatus for the safe handling of infectious materials in laboratory activities in order to reduce or eliminate exposure of workers, other people and the external environment to potentially hazardous agents.

In this context, a further distinction is made between primary containment (the protection of personnel and their immediate environment from exposure to infectious agents is ensured by laboratory procedures involving good microbiological practice, appropriate laboratory equipment (e.g. BSC) and personal protective equipment (e.g. PPE). In this case, vaccination may help to increase the level of personal protection. Secondary containment relates to the protection of the environment outside the laboratory from exposure to infectious materials, which is ensured by a combination of laboratory design and operating procedures (e.g. waste disposal).


It is clear that complying with Biosafety Levels in the context of Life Science requires procedures and good practices, personal protective equipment, as well as appropriate technology to ensure maximum health protection for operational staff and the public. Relying on an experienced partner who can design these places making them compliant and who can provide adequate washing, sterilization and containment solutions is essential. Cisa Group Bridging Science and Life.

Bridging science and life

Related Products



Via E. Mattei, snc, Angolo Via la Viaccia
55100 Lucca – Italy
C.F./P.IVA 02649850464.


T +39 0583 15381

CISA Production S.R.L.

Via E. Mattei, snc Angolo Via la Viaccia
55100 Lucca, Italy
CCIAA: LU 216451
C.F. / P.IVA / R.I. Lucca 12435741009
Capitale Sociale € 3.300.000 i.v.

Cisa Brasile Ltda ®

Todos os direitos reservados
Rua Dona Francisca, 8300 – Distrito Industrial, Bloco I, Módulo 1, 2 e 3
CEP: 89219-600 – Joinville – Santa Catarina – Brasil

Data Protection Officer (DPO):

© Copyright CISA 2023.
All rights reserved. For more details, please visit the Download section of the CISA website.